Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM

Recruiting now · Not applicable

Conditions studied: Diabetes Mellitus, Type 1, Immunologic Deficiency Syndromes

In brief

This study evaluates the efficacy of sequential transplantation of umbilical cord blood stem cells and islet cells in children with monogenic immunodeficiency type 1 diabetes mellitus. Umbilical cord blood stem cell transplantation will be performed first. Children with stable immune reconstruction will than receive islet cell transplantation.

Key facts

Study ID
NCT03835312
Run by
Children's Hospital of Fudan University
People needed
50
Starts
2019-02-20
Expected to finish
2030-12-31
Last updated by the study team
2026-03-17

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.